Trial intelligence / Profile preview

Two vs Four Weeks of Antibiotics for Septic Arthritis

NCT03615781Completed

Start
Jun 2015
Primary completion
Apr 2018
Countries
1
01

Overview

Randomised, open-label trial in septic arthritis (2 arms). Primary endpoints: Clinical Remission of systemic infection at 6 months and Sequels at 6 months. Started Jun 2015; status: completed.

02

Conditions

septic arthritis

Beyond the preview

Go deeper on NCT03615781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03615781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call